New test for kidney disease could reduce dialysis need
A new non-invasive test for kidney disease, developed by clinicians at Hammersmith Hospitals NHS Trust and Imperial College London, is providing a simple, safe, cheap and reliable method of detecting kidney disease. The new test, reported today in the journal Nephrology Dialysis Transplantation, can detect disease before symptoms become apparent, and offers a quicker way of finding out if patients are responding to treatment – which could mean that some patients might not need costly dialysis.
Around 100,000 people in the UK have kidney disease, and the number is increasing, costing the NHS over £2 billion annually. Over 7000 people die from kidney failure every year. “Patients with a progressive kidney disease due to vasculitis* often develop kidney failure, the only treatment for which is dialysis or kidney transplant,” explains Dr Fred Tam, consultant nephrologist at Charing Cross and Hammersmith Hospitals and senior lecturer at Imperial College London. “By looking at a chemical produced when the kidney becomes inflamed, we can test patient’s urine for the level of disease, often before clinical symptoms appear.” The test could eventually replace the need to take biopsies from the kidney – a complicated and uncomfortable surgical procedure.
Current treatments for kidney vasculitis involve using drugs that knock out the body’s immune system. These drugs can cause side effects, including vulnerability to infection and risk of reduced fertility. This new test can accurately measure response to treatment, allowing clinicians to tailor treatments to individual patients. “The test can tell us if a treatment is working, and shows us, before it is too late, if we need to change the medication, without the need to perform a biopsy,” adds Dr Tam.
The test works by identifying the amount of a cytokine molecule called monocyte chemoattractant protein-1 (MCP-1) present in the urine. MCP-1 is produced by the body as a response to inflammation, and attracts white blood cells to the area to combat pathogens. However, overreaction of the white blood cells may also cause vasculitis and organ damage. Each test costs less than £20 to administer. Kidney dialysis costs around £29,000 per year for one patient.
Mr Noureddine Khallouki from North London was admitted to Hammersmith hospital earlier this year suffering from renal vasculitis, and volunteered to take part in trialling the MCP-1 test. “I was happy to help out, as I think it’s important to give something back. Any new developments that reduce the need to take biopsies is a good thing – the procedure is uncomfortable and meant I was unable to move for about 8 hours afterwards in case of bleeding.” The test showed that Mr Khallouki was responding well to treatment and he has since made a full recovery.
Simon Wilde | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...